Evidence map›Paper›PMID 23548911›Full record

ArticleThe Journal of biological chemistry2013

Mycobacterium tuberculosis RNA polymerase-binding protein A (RbpA) and its interactions with sigma factors.

Alessio Bortoluzzi, Frederick W Muskett, Lorna C Waters, Philip W Addis, Barbara Rieck, Thomas Munder, Susanne Schleier, Francesca Forti, Daniela Ghisotti, Mark D Carr and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. CarD contributes to diverse gene expression outcomes throughout the genome ofProceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Fidaxomicin jamseLife · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 3 countries.

Alessio BortoluzziDepartment of Biochemistry, Immunity and Inflammation, University of Leicester, Leicester LE1 9HN, United Kingdom.
Frederick W MuskettDepartment of Biochemistry, Immunity and Inflammation, University of Leicester, Leicester LE1 9HN, United Kingdom.
Lorna C WatersDepartment of Biochemistry, Immunity and Inflammation, University of Leicester, Leicester LE1 9HN, United Kingdom.
Philip W AddisDepartment of Biochemistry, Immunity and Inflammation, University of Leicester, Leicester LE1 9HN, United Kingdom.
Barbara RieckDepartment of Infection, Immunity and Inflammation, University of Leicester, Leicester LE1 9HN, United Kingdom.
Thomas MunderDepartment of Cell and Molecular Biology, Leibniz Institute for Natural Product Research and Infection Biology e.V.-Hans Knöll Institute, D-07745 Jena, Germany.
Susanne SchleierDepartment of Cell and Molecular Biology, Leibniz Institute for Natural Product Research and Infection Biology e.V.-Hans Knöll Institute, D-07745 Jena, Germany.
Francesca FortiDipartimento di BioScienze, Università degli Studi di Milano, 20133 Milan, Italy.
Daniela GhisottiDipartimento di BioScienze, Università degli Studi di Milano, 20133 Milan, Italy.
Mark D CarrDepartment of Biochemistry, Immunity and Inflammation, University of Leicester, Leicester LE1 9HN, United Kingdom. Electronic address: mdc12@le.ac.uk.
Helen M O'HareDepartment of Biochemistry, Immunity and Inflammation, University of Leicester, Leicester LE1 9HN, United Kingdom; Department of Infection, Immunity and Inflammation, University of Leicester, Leicester LE1 9HN, United Kingdom. Electronic address: hmo7@le.ac.uk.
University of Leicester · GBLeibniz-Institut für Naturstoff-Forschung und Infektionsbiologie e. V. - Hans-Knöll-Institut (HKI) · DEUniversity of Milan · IT

Funding

Biotechnology and Biological Sciences Research Council BB/H007865/1
6 · The paper itself

Abstract

RNA polymerase-binding protein A (RbpA), encoded by Rv2050, is specific to the actinomycetes, where it is highly conserved. In the pathogen Mycobacterium tuberculosis, RbpA is essential for growth and survival. RbpA binds to the β subunit of the RNA polymerase where it activates transcription by unknown mechanisms, and it may also influence the response of M. tuberculosis to the current frontline anti-tuberculosis drug rifampicin. Here we report the solution structure of RbpA and identify the principle sigma factor σ(A) and the stress-induced σ(B) as interaction partners. The protein has a central ordered domain with a conserved hydrophobic surface that may be a potential protein interaction site. The N and C termini are highly dynamic and are involved in the interaction with the sigma factors. RbpA forms a tight complex with the N-terminal domain of σ(B) via its N- and C-terminal regions. The interaction with sigma factors may explain how RbpA stabilizes sigma subunit binding to the core RNA polymerase and thereby promotes initiation complex formation. RbpA could therefore influence the competition between principal and alternative sigma factors and hence the transcription profile of the cell.

Indexed as

MutationActinobacteriaBacterial ProteinsBinding SitesDNA-Directed RNA PolymerasesGenetic Complementation TestMagnetic Resonance SpectroscopyModels, MolecularMycobacterium tuberculosisPhenotypeProtein BindingProtein ConformationProtein Structure, TertiarySigma FactorTrans-ActivatorsTranscription, GeneticBacterial ProteinsDNA-Directed RNA PolymerasesRNA polymerase sigma ASigma FactorTrans-ActivatorsMycobacterium tuberculosisNMRProtein StructureRbpARNA PolymeraseSigma FactorTranscriptionTuberculosis

Identifiers

PMID23548911
PMCPMC3656299
OpenAlexW2042329136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.